Title: Yonhap News– Daedeok Innopolis, '2009 Technoglogy Commercialization Awards'

Publication: Yonhap News/ Joon Ho Kim

Date: 01 October 2011

Summary

• Daedeok Innopolis Headquater hosted "2009 Daedeok Innopolis Technical Commercialization Awards" in Daejeon Convention Center.

• The awards were to recognize exemplary technological commercialization cases of the companies in Daedeok innopolis, and LegoChem won excellence award.

•  

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).